Meyka Pro banner
MeiraGTx Holdings plc

MeiraGTx Holdings plc (MGTX) Stock Overview

Explore MeiraGTx Holdings plc’s financial performance, market position, analyst ratings, and future outlook.

MGTXNASDAQ
HealthcareBiotechnology
$12.30
$0.53(4.50%)
U.S. Market opens in 15h 20m

MeiraGTx Holdings plc (MGTX)

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio-8.41
EPS (TTM)$-1.48
ROE4.75%
Fundamental Analysis

AI Price Forecasts

1 Month$10.98
3 Months$14.50
1 Year Target$12.79

MGTX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of MeiraGTx Holdings plc (NASDAQ: MGTX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, MeiraGTx Holdings plc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MGTX on the NASDAQ shows an RSI of 52.94, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $12.79 for the NASDAQ listing.

Key metrics behind MeiraGTx Holdings plc's NASDAQ-traded stock include a P/E ratio of -8.41 and a market capitalization of 1.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MGTX on the NASDAQ.

Price Performance (NASDAQ: MGTX)

1-Day Change
4.50%
5-Day Change
0.41%
1-Month Change
1.57%
3-Month Change
34.72%
6-Month Change
53.56%
Year-to-Date (YTD) Change
54.72%
1-Year Change
49.45%
3-Year Change
109.18%
5-Year Change
-13.01%
All-Time (Max) Change
-18.00%

Contact Information

646 860 7985
655 Third Avenue, New York City, NY, 10016

Company Facts

4,090 Employees
IPO DateJun 8, 2018
CountryUS
Actively Trading

Frequently Asked Questions